CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This study aims to explore the genetic and epigenetic factors that lead to microRNA deregulation in colorectal cancer. It seeks to identify potential therapeutic targets by analyzing mutations and their effects on cancer progression, ultimately contributing to drug development.
MicroRNAs are small non-coding RNAs involved in cell homeostasis and carcinogenesis.
MicroRNA deregulation is associated with colorectal cancer (CRC) progression.
My study proposes to identify genetic and epigenetic events leading to microRNAs deregulation and use them as targets for drug development.
My research proposal will address two important questions.
First it will assess the contribution of genetic and epigenetic events in controlling microRNA genes and cancer phenotype.
Second it will…
INSTITUTE OF CANCER RESEARCH: THE ROYAL CANCER HOSPITAL LBG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, Glasgow
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
